Life & Times
The impact on general practice of prescribing assisted dying drugs
Claud Regnard, Carol Davis, Katherine Sleeman, Philip Williams and Ana Worthington
British Journal of General Practice 2021; 71 (712): 516. DOI: https://doi.org/10.3399/bjgp21X717605
Claud Regnard
Palliative Medicine, St. Oswald’s Hospice, Newcastle-upon-Tyne. Email:
Roles: Honorary consultant
Carol Davis
University Hospital Southampton NHS Foundation Trust.
Roles: Consultant in Palliative Medicine and Clinical Lead for End-of-Life Care
Katherine Sleeman
National Institute for Health Research Clinician Scientist and Honorary Consultant in Palliative Medicine, Kings College London.
Roles: Laing Galazka Professor of Palliative Care
Philip Williams
Nettleham Medical Practice, Lincolnshire.
Roles: GP
Ana Worthington
Keble College, University of Oxford.
Roles: Postgraduate Student
In this issue
British Journal of General Practice
Vol. 71, Issue 712
November 2021
The impact on general practice of prescribing assisted dying drugs
Claud Regnard, Carol Davis, Katherine Sleeman, Philip Williams, Ana Worthington
British Journal of General Practice 2021; 71 (712): 516. DOI: 10.3399/bjgp21X717605
More in this TOC Section
Related Articles
Cited By...
Intended for Healthcare Professionals